IRIS
Del Re, Marzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 841
SA - Sud America 543
NA - Nord America 236
EU - Europa 147
AF - Africa 37
OC - Oceania 3
Totale 1.807
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 471
SG - Singapore 351
US - Stati Uniti d'America 190
CN - Cina 158
VN - Vietnam 130
HK - Hong Kong 85
IT - Italia 74
MX - Messico 28
AR - Argentina 27
BD - Bangladesh 22
IQ - Iraq 18
EC - Ecuador 16
GB - Regno Unito 15
IN - India 15
ID - Indonesia 13
CO - Colombia 10
RU - Federazione Russa 10
ZA - Sudafrica 10
NL - Olanda 9
TR - Turchia 9
UA - Ucraina 8
DE - Germania 6
ES - Italia 6
SA - Arabia Saudita 6
VE - Venezuela 6
CA - Canada 5
EG - Egitto 5
KE - Kenya 5
UY - Uruguay 5
AZ - Azerbaigian 4
FR - Francia 4
NP - Nepal 4
TN - Tunisia 4
UZ - Uzbekistan 4
CL - Cile 3
DZ - Algeria 3
IE - Irlanda 3
KZ - Kazakistan 3
NO - Norvegia 3
PK - Pakistan 3
PY - Paraguay 3
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
FI - Finlandia 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PH - Filippine 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KR - Corea 1
MD - Moldavia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RW - Ruanda 1
SE - Svezia 1
SO - Somalia 1
SV - El Salvador 1
TJ - Tagikistan 1
UG - Uganda 1
Totale 1.807
Salva come PNG Salva come JPEG
Città #
Singapore 232
Hong Kong 77
Beijing 71
Ho Chi Minh City 66
Rome 36
Ashburn 29
São Paulo 25
Mexico City 20
Hanoi 17
Rio de Janeiro 17
Milan 14
Santa Clara 14
Brasília 10
Ribeirão Preto 9
Haiphong 8
Belo Horizonte 7
Campinas 7
Curitiba 7
New York 7
Da Nang 6
Dhaka 6
Salvador 6
São José dos Campos 6
Biên Hòa 5
Fortaleza 5
Guayaquil 5
Nairobi 5
Osasco 5
Baku 4
Bogotá 4
Canoas 4
Cape Town 4
Erbil 4
Guarulhos 4
Montevideo 4
Porto Alegre 4
Quito 4
Rondonópolis 4
Tashkent 4
Taubaté 4
Vitória da Conquista 4
Anápolis 3
Araraquara 3
Atlanta 3
Belém 3
Ceres 3
Council Bluffs 3
Duque de Caxias 3
Goiânia 3
Houston 3
Istanbul 3
Juazeiro do Norte 3
Kathmandu 3
Manaus 3
Natal 3
Niterói 3
Passo Fundo 3
Pelotas 3
Quận Mười 3
San Antonio 3
Santo André 3
Tunis 3
10th of Ramadan City 2
Alfenas 2
Ambato 2
Amman 2
Aracaju 2
Asunción 2
Baghdad 2
Baltimore 2
Barbacena 2
Bauru 2
Bento Gonçalves 2
Boston 2
Buenos Aires 2
Cairo 2
Campo Largo 2
Campo Novo do Parecis 2
Can Tho 2
Caracas 2
Caraguatatuba 2
Cartagena 2
Catanduva 2
Caxias do Sul 2
Cleveland 2
Dammam 2
Dublin 2
El Paso 2
Extrema 2
Formosa 2
Governador Valadares 2
Greenville 2
Ha Long 2
Helsinki 2
Iapu 2
Ipatinga 2
Itajaí 2
Jacksonville 2
Jaipur 2
Jeddah 2
Totale 913
Salva come PNG Salva come JPEG
Nome #
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 24
EGFR signaling pathway as therapeutic target in human cancers 23
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 18
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 18
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 18
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer 18
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 17
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 17
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 16
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies 16
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 16
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 16
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 15
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 15
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 15
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 15
ANKRd44 gene silencing: A putative role in trastuzumab resistance in HER2-like breast cancer 15
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 15
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 14
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 14
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma 14
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 14
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data 14
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 14
Recommendations for using molecular assays on liquid biopsy: the first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC | Raccomandazioni per l’esecuzione di indagini molecolari su biopsia liquida in oncologia 14
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 14
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 14
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 14
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy 13
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 13
Results of a comprehensive pharmacogenetic analysis of dihydropyrimidine dehydrogenase in patients treated with fluoropyrimidines and patterns of polymorphisms partially related to treatment tolerability 13
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 13
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 13
Predicting Fluoropyrimidine-Related Toxicity: Turning Wish to Will, The Pamm-Eortc Position 13
Genome Wide Association Studies (GWAS) 13
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 13
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 13
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 13
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 13
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project 13
Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC 13
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 13
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers 13
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 13
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation 12
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 12
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 12
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA 12
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 12
Facing an un-met need in lung cancer screening: The never smokers 12
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 12
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis 12
Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity 12
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 12
Empower the potential of trastuzumab deruxtecan with novel combinations 12
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 12
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 12
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 12
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 12
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 12
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 12
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 12
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice 12
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 12
Cross-Linked Hyaluronic Acid as Tear Film Substitute 12
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials 12
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 11
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 11
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA 11
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 11
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 11
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 11
Crizotinib resensitization by compound mutation 11
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 11
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 11
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 11
Clinical relevance and methodological approach for the assessment of drug-drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) 11
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 11
Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? 11
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight 11
Response to Wirostko et al. Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. (J Ocul Pharmacol Ther 2019;35(7):381-387) 11
ErbB in NSCLC as a molecular target: Current evidences and future directions 11
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 11
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants 11
Understanding EGFR heterogeneity in lung cancer 11
Author's reply. The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients 11
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 11
Should CYP2D6 be genotyped when treating with tamoxifen? 11
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 11
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment 10
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 10
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation 10
Author's reply 10
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 10
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer 10
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 10
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm 10
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy 10
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines 10
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) 10
Totale 1.282
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.169 0 0 0 44 19 50 69 149 168 33 309 328
2025/2026845 176 38 271 244 116 0 0 0 0 0 0 0
Totale 2.014